Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
PaperCitations, authors & open-access status
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 77 citations, 2025 year and green oa status.
77
Citations
2025
Year
green
OA Status